Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.

Liang X, He M, Chen T, Liu Y, Tian YL, Wu YL, Zhao Y, Shen Y, Yuan ZY.

Int J Mol Med. 2013 May;31(5):1066-74. doi: 10.3892/ijmm.2013.1323. Epub 2013 Mar 27.

PMID:
23545584
2.

Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.

Ortiz-Muñoz G, Martin-Ventura JL, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O, Muñoz-Garcia B, Fernandez-Vizarra P, Ortega L, Egido J, Gomez-Guerrero C.

Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):525-31. doi: 10.1161/ATVBAHA.108.173781. Epub 2009 Jan 22.

3.

The expression of SOCS is altered in rheumatoid arthritis.

Isomäki P, Alanärä T, Isohanni P, Lagerstedt A, Korpela M, Moilanen T, Visakorpi T, Silvennoinen O.

Rheumatology (Oxford). 2007 Oct;46(10):1538-46. Epub 2007 Aug 27.

PMID:
17726036
4.

Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.

Norkina O, Dolganiuc A, Catalano D, Kodys K, Mandrekar P, Syed A, Efros M, Szabo G.

Alcohol Clin Exp Res. 2008 Sep;32(9):1565-73. doi: 10.1111/j.1530-0277.2008.00726.x. Epub 2008 Jul 9.

5.

Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice.

Recio C, Oguiza A, Mallavia B, Lazaro I, Ortiz-Muñoz G, Lopez-Franco O, Egido J, Gomez-Guerrero C.

Basic Res Cardiol. 2015 Mar;110(2):8. doi: 10.1007/s00395-014-0458-1. Epub 2015 Jan 21.

PMID:
25604439
6.

The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.

Wormald S, Zhang JG, Krebs DL, Mielke LA, Silver J, Alexander WS, Speed TP, Nicola NA, Hilton DJ.

J Biol Chem. 2006 Apr 21;281(16):11135-43. Epub 2006 Feb 10.

7.

Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Girolami EI, Bouhy D, Haber M, Johnson H, David S.

Exp Neurol. 2010 May;223(1):173-82. doi: 10.1016/j.expneurol.2009.06.018. Epub 2009 Jul 2.

8.

Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.

Chen CH, Chen HA, Liao HT, Liu CH, Tsai CY, Chou CT.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):100-5. Epub 2016 Jan 20.

PMID:
26812031
9.

Differentiated miRNA expression and validation of signaling pathways in apoE gene knockout mice by cross-verification microarray platform.

Han H, Wang YH, Qu GJ, Sun TT, Li FQ, Jiang W, Luo SS.

Exp Mol Med. 2013 Mar 8;45:e13. doi: 10.1038/emm.2013.31.

10.

Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.

Cooper JC, Shi M, Chueh FY, Venkitachalam S, Yu CL.

Int J Oncol. 2010 May;36(5):1201-8.

11.

Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis.

Masood KI, Rottenberg ME, Salahuddin N, Irfan M, Rao N, Carow B, Islam M, Hussain R, Hasan Z.

BMC Infect Dis. 2013 Jan 15;13:13. doi: 10.1186/1471-2334-13-13.

12.

Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.

Sukka-Ganesh B, Larkin J 3rd.

Scand J Immunol. 2016 Nov;84(5):299-309. doi: 10.1111/sji.12475.

13.

Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme.

Zhou H, Miki R, Eeva M, Fike FM, Seligson D, Yang L, Yoshimura A, Teitell MA, Jamieson CA, Cacalano NA.

Clin Cancer Res. 2007 Apr 15;13(8):2344-53.

14.

Pravastatin attenuates interferon-gamma action via modulation of STAT1 to prevent aortic atherosclerosis in apolipoprotein E-knockout mice.

Zhou XX, Gao PJ, Sun BG.

Clin Exp Pharmacol Physiol. 2009 Apr;36(4):373-9. doi: 10.1111/j.1440-1681.2008.05067.x. Epub 2008 Oct 31.

PMID:
19018808
15.

Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease.

Rastmanesh MM, Bluyssen HA, Joles JA, Boer P, Willekes N, Braam B.

Eur J Pharmacol. 2008 Sep 28;593(1-3):99-104. doi: 10.1016/j.ejphar.2008.07.013. Epub 2008 Jul 12.

PMID:
18656467
16.

IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.

Zimmerer JM, Lesinski GB, Kondadasula SV, Karpa VI, Lehman A, Raychaudhury A, Becknell B, Carson WE 3rd.

J Immunol. 2007 Apr 15;178(8):4832-45.

17.

Production of interferon α and β, pro-inflammatory cytokines and the expression of suppressor of cytokine signaling (SOCS) in obese subjects infected with influenza A/H1N1.

Terán-Cabanillas E, Montalvo-Corral M, Silva-Campa E, Caire-Juvera G, Moya-Camarena SY, Hernández J.

Clin Nutr. 2014 Oct;33(5):922-6. doi: 10.1016/j.clnu.2013.10.011. Epub 2013 Oct 23.

PMID:
24182768
18.

SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway.

Cittadini A, Monti MG, Iaccarino G, Castiello MC, Baldi A, Bossone E, Longobardi S, Marra AM, Petrillo V, Saldamarco L, During MJ, Saccà L, Condorelli G.

Cardiovasc Res. 2012 Dec 1;96(3):381-90. doi: 10.1093/cvr/cvs261. Epub 2012 Aug 8.

19.

miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.

Collins AS, McCoy CE, Lloyd AT, O'Farrelly C, Stevenson NJ.

PLoS One. 2013 Jul 22;8(7):e69090. doi: 10.1371/journal.pone.0069090. Print 2013.

20.

Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.

Vartoukian SR, Tilakaratne WM, Seoudi N, Bombardieri M, Bergmeier L, Tappuni AR, Fortune F.

Clin Exp Immunol. 2014 Sep;177(3):618-29. doi: 10.1111/cei.12377.

Supplemental Content

Support Center